Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Levin Rami — CNS Pharmaceuticals, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Levin Rami

Levin Rami

Director at CNS Pharmaceuticals, Inc. · on record since Jan 2, 2026
CEO and President at CNS Pharmaceuticals, Inc. · on record since Jan 2, 2026

Insider trading activity of Levin Rami

Transactions on record: 1; since Jan 2, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jan 2, 2026

Figures computed from official regulatory filings — methodology.

Companies where Levin Rami has traded

CNS Pharmaceuticals, Inc.1 tx · Jan 2, 2026

Track record of Levin Rami

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Levin Rami

Co-insiders of Levin Rami

Andraczke AndrzejCNS Pharmaceuticals, Inc.
Charles Faith L.CNS Pharmaceuticals, Inc.
Climaco John MCNS Pharmaceuticals, Inc.
Cockroft Bettina M.CNS Pharmaceuticals, Inc.
Cortice Biosciences, Inc.CNS Pharmaceuticals, Inc.
Downs ChristopherCNS Pharmaceuticals, Inc.
Evans Carl AnthonyCNS Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Faulkner EricCNS Pharmaceuticals, Inc.

Gumulka JerzyCNS Pharmaceuticals, Inc.

Keyes Jeffry R.CNS Pharmaceuticals, Inc.

Mahery AmyCNS Pharmaceuticals, Inc.

O'Loughlin SteveCNS Pharmaceuticals, Inc.

Priebe WaldemarCNS Pharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
CNS Pharmaceuticals, Inc.	Jan 2, 2026	AwardD	19,000	—	—	SEC